Filing Details
- Accession Number:
- 0001209191-17-002652
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-01-06 16:28:39
- Reporting Period:
- 2017-01-04
- Filing Date:
- 2017-01-06
- Accepted Time:
- 2017-01-06 16:28:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1598646 | Minerva Neurosciences Inc. | NERV | Pharmaceutical Preparations (2834) | 260784194 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1617236 | S. Mark Levine | C/O Minerva Neurosciences, Inc. 1601 Trapelo Road, Suite 284 Waltham MA 02451 | Svp,General Counsel & Sec. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-01-04 | 17,250 | $4.71 | 17,250 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-01-04 | 250 | $5.19 | 17,500 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-01-04 | 17,500 | $12.00 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-01-04 | 17,250 | $0.00 | 17,250 | $4.71 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-01-04 | 250 | $0.00 | 250 | $5.19 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 51,750 | 2025-12-03 | No | 4 | M | Direct | |
| 57,274 | 2025-04-13 | No | 4 | M | Direct |
Footnotes
- These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 22, 2016.
- This option vests as follows: 25% on December 4, 2016 and then in quarterly installments over 3 years thereafter.
- This option vests as follows: 25% on April 14, 2016; and then in quarterly installments over 3 years thereafter.
Billionaire Hedge Funds
